CatalystFDA/Bio

BIOVIE INC. (BIVI) DISCUSSION OF PHASE 2 DATA ON BEZISTERIM IN LONG COVID AND PARKINSON'S WITH FOCUS ON INFLAMMATION TARGETS TRANSCRIPT - SEEKINGALPHA

Phase 2 data on bezisterim in Long COVID and Parkinson's targets inflammation.

What changed

Phase 2 data on bezisterim in Long COVID and Parkinson's targets inflammation.

Why it matters

Phase 2 data on bezisterim in Long COVID and Parkinson's targets inflammation. — impact context not separately stored; see What changed.

Sources